Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceutical...

FDA Recall #D-1250-2020 — Class II — April 20, 2020

Recall #D-1250-2020 Date: April 20, 2020 Classification: Class II Status: Terminated

Product Description

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

Reason for Recall

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

11,808 bottles

Distribution

Product was distributed Nationwide in the United States.

Code Information

Lot # Q000255, Exp 01/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated